# AKTIBIPO-VALIDATION: A Study to Validate Benefits of Mindpax System in Managing Bipolar Disorder

> **NCT04945057** · NA · UNKNOWN · sponsor: **National Institute of Mental Health, Czech Republic** · enrollment: 130 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DEVICE:** Mindpax monitoring system

## Key facts

- **NCT ID:** NCT04945057
- **Lead sponsor:** National Institute of Mental Health, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-05
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2022-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04945057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04945057, "AKTIBIPO-VALIDATION: A Study to Validate Benefits of Mindpax System in Managing Bipolar Disorder". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT04945057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*